CLO players eye make or break summer for Valeant
Valeant Pharmaceuticals is facing an important test in its ability to reverse its fortunes this summer, as CLO market players say that the fate of the Canadian pharmaceutical giant will have a substantial effect on the sector.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: